Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,191 | -7,396 | -4,409 | -2,432 | -10,665 |
| Depreciation Amortization | 974 | 747 | 479 | 248 | 4,973 |
| Accounts receivable | -136 | -66 | 31 | -274 | -294 |
| Accounts payable and accrued liabilities | -633 | -214 | -631 | 1,216 | 85 |
| Other Working Capital | -702 | -172 | -201 | 806 | 79 |
| Other Operating Activity | 1,116 | 474 | 550 | -875 | -1,556 |
| Operating Cash Flow | $-9,572 | $-6,628 | $-4,181 | $-1,312 | $-7,377 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -221 | -54 | -57 | N/A | -505 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -189 |
| Investing Cash Flow | $-221 | $-54 | $-57 | $N/A | $-694 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,561 | 14,555 | 1,342 | N/A | 2,555 |
| Other Financing Activity | 0 | 0 | 2,444 | 0 | -1,119 |
| Financing Cash Flow | $14,561 | $14,555 | $3,786 | $0 | $1,435 |
| Exchange Rate Effect | -1 | -13 | 33 | -39 | -65 |
| Beginning Cash Position | 1,537 | 1,537 | 1,537 | 1,537 | 8,238 |
| End Cash Position | 6,304 | 9,398 | 1,119 | 186 | 1,537 |
| Net Cash Flow | $4,767 | $7,860 | $-418 | $-1,351 | $-6,701 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,572 | -6,628 | -4,181 | -1,312 | -7,377 |
| Capital Expenditure | -221 | -54 | -57 | N/A | -505 |
| Free Cash Flow | -9,793 | -6,682 | -4,238 | -1,312 | -7,883 |